Human CD137 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human CD137 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD137 |
| Clone | [4B4-1] |
| Host Species | n/a |
| Reactive Species | n/a |
| Isotype | IgG1k |
| Format | Protein A purified |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Human CD137 (4-1BB) is expressed on activated T cells within 24-48 hours of activation (3). CD137 is a type I membrane protein and a member of the tumor necrosis factor receptor superfamily (1,2). CD137 appears to be important for T cell proliferation and survival (4) and induces monocyte activation (5). |
| Immunogen | Immunogen: Ectodomain of human 4-1BB fusion protein s. Buffer: 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl. Product was sterile filtered and vialed under aseptic conditions. No preservative added. |
| Other Names | [CD137F(ab')2 (Preservative-free); human CD137 (4-1BB) F(ab')2*], [4-1BB] |
| Gene, Accession # | [CD137], Gene ID: 102127961, NCBI: ABY47575.1 |
| Catalog # | MBS666885 |
| Price | $1020 |
| Order / More Info | Human CD137 Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. M.R. Alderson, et al, (1994) Eur J Immunol 24: 2219-2227. 2. H.J. Gruss, and S.K. Dower, (1995) Blood 85: 3378-3404. 3. B.A. Garni-Wagner, et al, (1996) Cellular Immunol 169: 91-98. 4. H. Schwarz, et al, (1996) Blood 87: 2839-2845. 5. J. Langstein, H. Schwartz, et al, (1998) J Immunol 160: 2488-2494. 6. G. Kienzle, J. von Kempis, (1999) Int Immunol 12(1): 73-82. 7. Baessler T, H R Salih, et al. (2009) 115(15): 3058-3069. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies